| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |